TITLE:
      Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea
SUMMARY:
      This post marketing surveillance study in Korea will evaluate the safety and efficacy of
      BOTOX (botulinum toxin Type A) in patients who receive treatment according to standard of
      care for primary axillary hyperhidrosis, focal spasticity or moderate to severe glabellar
      lines in clinical practice.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  Patients treated with BOTOX® (botulinum toxin Type A) as prescribed according to
             standard of care in clinical practice for primary axillary hyperhidrosis, focal
             spasticity or moderate to severe glabellar lines.

        Exclusion Criteria:
